Products Dexmedetomidine is commercially available as a concentrate for the preparation of an infusion solution (Dexdor). It was approved in many countries in 2012. Structure and properties Dexmedetomidine (C13H16N2, Mr = 200.3 g/mol) is an imidazole derivative and the -enantiomer of medetomidine. It is structurally closely related to detomidine and is present in drugs as … Dexmedetomidine
Products Medetomidine is commercially available as an injection solution for animals. It has been approved in many countries since 1990. Structure and properties Medetomidine (C13H16N2, Mr = 200.3 g/mol) is an imidazole derivative that is structurally closely related to detomidine. Medetomidine is a racemate; the pure -enantiomer dexmedetomidine is also used. Effects Medetomidine (ATCvet QN05CM91) … Medetomidine
Products Detomidine is commercially available as a solution for injection and a gel (Domosedan, Equisedan, Medesedan). It has been approved in many countries since 1990. Structure and properties Detomidine (C12H14N2, Mr = 186.3 g/mol) is an imidazole derivative. It is structurally closely related to medetomidine. Effects Detomidine (ATCvet QN05CM90) is sedative, analgesic, and muscle relaxant. … Detomidine
Products Atipamezole is commercially available as a solution for injection as a veterinary drug. It has been approved in many countries since 1990. Structure and properties Atipamezole (C14H16N2, Mr = 212.3 g/mol) is an imidazole derivative. Effects Atipamezole (ATCvet QV03AB90) is an α2 antagonist and abolishes the sedative effects of medetomidine. Indications To abolish the … Atipamezole
